UGT1A1 and Decreased total neutrophil count: We studied the relation between the safety of irinotecan-based regimens and UGT1A1 genotype and developed a nomogram to predict the risk of irinotecan-induced severe neutropenia in 1312 advanced colorectal cancer patients registered in a prospective observational study.